Ghent University Academic Bibliography

Advanced

Cardiovascular toxicity of cancer treatment

MATTHIEU COMBES UGent, Sylvie Rottey UGent and Tine De Backer UGent (2011) ACTA CLINICA BELGICA. 66(4). p.260-266
abstract
Drugs with potential cardiac toxicity are prominent in cancer treatment, not only the old chemotherapeutic agents, but also the newer targeted drugs and biologic agents. As the long-term survival of patients with malignancies has improved and cancer turned into a chronic disease, physicians must take into account the short-term as well as long-term consequences of cancer treatment, such as chemotherapy-induced cardiotoxicity. We summarize some general characteristics and subsequently review specific antineoplastic agents that are associated with cardiac toxicity.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
cardiotoxicity, chemotherapy agents, targeted drugs, CARDIOTOXICITY, THERAPY, DRUGS, COMPLICATIONS, PATHOGENESIS, MANAGEMENT, DIAGNOSIS
journal title
ACTA CLINICA BELGICA
Acta Clin. Belg.
volume
66
issue
4
pages
260 - 266
Web of Science type
Article
Web of Science id
000295022700003
JCR category
MEDICINE, GENERAL & INTERNAL
JCR impact factor
0.592 (2011)
JCR rank
105/153 (2011)
JCR quartile
3 (2011)
ISSN
0001-5512
DOI
10.2143/ACB.66.4.2062566
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1998700
handle
http://hdl.handle.net/1854/LU-1998700
date created
2012-01-20 15:15:24
date last changed
2015-06-17 09:54:56
@article{1998700,
  abstract     = {Drugs with potential cardiac toxicity are prominent in cancer treatment, not only the old chemotherapeutic agents, but also the newer targeted drugs and biologic agents. 
As the long-term survival of patients with malignancies has improved and cancer turned into a chronic disease, physicians must take into account the short-term as well as long-term consequences of cancer treatment, such as chemotherapy-induced cardiotoxicity. 
We summarize some general characteristics and subsequently review specific antineoplastic agents that are associated with cardiac toxicity.},
  author       = {COMBES, MATTHIEU and Rottey, Sylvie and De Backer, Tine},
  issn         = {0001-5512},
  journal      = {ACTA CLINICA BELGICA},
  keyword      = {cardiotoxicity,chemotherapy agents,targeted drugs,CARDIOTOXICITY,THERAPY,DRUGS,COMPLICATIONS,PATHOGENESIS,MANAGEMENT,DIAGNOSIS},
  language     = {eng},
  number       = {4},
  pages        = {260--266},
  title        = {Cardiovascular toxicity of cancer treatment},
  url          = {http://dx.doi.org/10.2143/ACB.66.4.2062566},
  volume       = {66},
  year         = {2011},
}

Chicago
Combes, Matthieu, Sylvie Rottey, and Tine De Backer. 2011. “Cardiovascular Toxicity of Cancer Treatment.” Acta Clinica Belgica 66 (4): 260–266.
APA
Combes, M., Rottey, S., & De Backer, T. (2011). Cardiovascular toxicity of cancer treatment. ACTA CLINICA BELGICA, 66(4), 260–266.
Vancouver
1.
Combes M, Rottey S, De Backer T. Cardiovascular toxicity of cancer treatment. ACTA CLINICA BELGICA. 2011;66(4):260–6.
MLA
Combes, Matthieu, Sylvie Rottey, and Tine De Backer. “Cardiovascular Toxicity of Cancer Treatment.” ACTA CLINICA BELGICA 66.4 (2011): 260–266. Print.